drugset / Trial / NCT05851066
A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a randomized, double blinded, phase 1 study. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single dose of VSA003 in healthy adult volunteerst
Timeline
- Start
- 2023-06-01
- Primary completion
- 2024-05-07
- Completion
- 2024-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VSA003 | Unknown | 50 mg | Subcutaneous |
| Subject | VSA003 | Unknown | 100 mg | Subcutaneous |
| Subject | VSA003 | Unknown | 200 mg | Subcutaneous |